25 XP   0   0   10

Resmed Inc DRC
Buy, Hold or Sell?

Let's analyse Resmed together

PenkeI guess you are interested in Resmed Inc DRC. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Resmed Inc DRC. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Resmed Inc DRC

I send you an email if I find something interesting about Resmed Inc DRC.

Quick analysis of Resmed (30 sec.)










What can you expect buying and holding a share of Resmed? (30 sec.)

How much money do you get?

How much money do you get?
$0.70
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
$2.80
Expected worth in 1 year
$4.86
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
$2.76
Return On Investment
15.6%

For what price can you sell your share?

Current Price per Share
$17.70
Expected price per share
$17.70 - $
How sure are you?
50%

1. Valuation of Resmed (5 min.)




Live pricePrice per Share (EOD)

$17.70

Intrinsic Value Per Share

$1.01 - $3.60

Total Value Per Share

$3.81 - $6.40

2. Growth of Resmed (5 min.)




Is Resmed growing?

Current yearPrevious yearGrowGrow %
How rich?$4.1b$3.3b$769.1m18.6%

How much money is Resmed making?

Current yearPrevious yearGrowGrow %
Making money$897.5m$779.4m$118.1m13.2%
Net Profit Margin21.3%21.8%--

How much money comes from the company's main activities?

3. Financial Health of Resmed (5 min.)




4. Comparing to competitors in the Medical Instruments & Supplies industry (5 min.)




  Industry Rankings (Medical Instruments & Supplies)  


Richest
#13 / 169

Most Revenue
#21 / 169

Most Profit
#13 / 169

What can you expect buying and holding a share of Resmed? (5 min.)

Welcome investor! Resmed's management wants to use your money to grow the business. In return you get a share of Resmed.

What can you expect buying and holding a share of Resmed?

First you should know what it really means to hold a share of Resmed. And how you can make/lose money.

Speculation

The Price per Share of Resmed is $17.70. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Resmed.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Resmed, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $2.80. Based on the TTM, the Book Value Change Per Share is $0.52 per quarter. Based on the YOY, the Book Value Change Per Share is $0.32 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.18 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Resmed.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.613.4%0.613.4%0.533.0%0.432.4%0.331.9%
Usd Book Value Change Per Share0.522.9%0.522.9%0.321.8%0.281.6%0.171.0%
Usd Dividend Per Share0.181.0%0.181.0%0.170.9%0.160.9%0.140.8%
Usd Total Gains Per Share0.693.9%0.693.9%0.492.8%0.442.5%0.311.7%
Usd Price Per Share21.82-21.82-22.00-12.28-6.14-
Price to Earnings Ratio35.84-35.84-41.52-23.80-11.90-
Price-to-Total Gains Ratio31.57-31.57-44.92-38.77-38.77-
Price to Book Ratio7.79-7.79-9.63-5.56-2.78-
Price-to-Total Gains Ratio31.57-31.57-44.92-38.77-38.77-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share17.7
Number of shares56
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.180.16
Usd Book Value Change Per Share0.520.28
Usd Total Gains Per Share0.690.44
Gains per Quarter (56 shares)38.7024.57
Gains per Year (56 shares)154.8198.29
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
139116145366388
27823130071126186
3118347455107188284
4157462610142251382
5196578765178314480
6235693920213377578
72758091075249439676
83149251230284502774
935310401385320565872
1039211561540355628970

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%31.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.01.00.090.0%29.02.00.093.5%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%14.00.017.045.2%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.01.00.090.0%30.01.00.096.8%

Fundamentals of Resmed

About Resmed Inc DRC

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. It operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. The company was founded in 1989 and is headquartered in San Diego, California.

Fundamental data was last updated by Penke on 2024-04-24 21:45:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is overpriced.

1.1. Profitability of Resmed Inc DRC.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Resmed earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Resmed to the Medical Instruments & Supplies industry mean.
  • A Net Profit Margin of 21.3% means that $0.21 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Resmed Inc DRC:

  • The MRQ is 21.3%. The company is making a huge profit. +2
  • The TTM is 21.3%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ21.3%TTM21.3%0.0%
TTM21.3%YOY21.8%-0.5%
TTM21.3%5Y18.9%+2.4%
5Y18.9%10Y18.7%+0.2%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ21.3%6.2%+15.1%
TTM21.3%6.2%+15.1%
YOY21.8%8.0%+13.8%
5Y18.9%7.3%+11.6%
10Y18.7%6.8%+11.9%
1.1.2. Return on Assets

Shows how efficient Resmed is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Resmed to the Medical Instruments & Supplies industry mean.
  • 13.3% Return on Assets means that Resmed generated $0.13 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Resmed Inc DRC:

  • The MRQ is 13.3%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 13.3%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ13.3%TTM13.3%0.0%
TTM13.3%YOY15.3%-2.0%
TTM13.3%5Y12.4%+0.9%
5Y12.4%10Y12.4%+0.0%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ13.3%1.2%+12.1%
TTM13.3%1.3%+12.0%
YOY15.3%1.9%+13.4%
5Y12.4%2.2%+10.2%
10Y12.4%2.0%+10.4%
1.1.3. Return on Equity

Shows how efficient Resmed is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Resmed to the Medical Instruments & Supplies industry mean.
  • 21.7% Return on Equity means Resmed generated $0.22 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Resmed Inc DRC:

  • The MRQ is 21.7%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 21.7%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ21.7%TTM21.7%0.0%
TTM21.7%YOY23.2%-1.5%
TTM21.7%5Y21.2%+0.6%
5Y21.2%10Y20.1%+1.0%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ21.7%2.5%+19.2%
TTM21.7%2.7%+19.0%
YOY23.2%3.7%+19.5%
5Y21.2%3.9%+17.3%
10Y20.1%3.8%+16.3%

1.2. Operating Efficiency of Resmed Inc DRC.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Resmed is operating .

  • Measures how much profit Resmed makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Resmed to the Medical Instruments & Supplies industry mean.
  • An Operating Margin of 27.0% means the company generated $0.27  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Resmed Inc DRC:

  • The MRQ is 27.0%. The company is operating very efficient. +2
  • The TTM is 27.0%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ27.0%TTM27.0%0.0%
TTM27.0%YOY28.0%-0.9%
TTM27.0%5Y26.6%+0.5%
5Y26.6%10Y25.8%+0.8%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ27.0%8.1%+18.9%
TTM27.0%7.6%+19.4%
YOY28.0%10.9%+17.1%
5Y26.6%10.1%+16.5%
10Y25.8%10.5%+15.3%
1.2.2. Operating Ratio

Measures how efficient Resmed is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • An Operation Ratio of 0.73 means that the operating costs are $0.73 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Resmed Inc DRC:

  • The MRQ is 0.727. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.727. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.727TTM0.7270.000
TTM0.727YOY0.720+0.007
TTM0.7275Y0.729-0.002
5Y0.72910Y0.743-0.014
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7271.153-0.426
TTM0.7271.168-0.441
YOY0.7201.105-0.385
5Y0.7291.097-0.368
10Y0.7431.056-0.313

1.3. Liquidity of Resmed Inc DRC.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Resmed is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A Current Ratio of 3.12 means the company has $3.12 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Resmed Inc DRC:

  • The MRQ is 3.122. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.122. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.122TTM3.1220.000
TTM3.122YOY2.802+0.320
TTM3.1225Y2.448+0.674
5Y2.44810Y3.229-0.781
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ3.1222.302+0.820
TTM3.1222.333+0.789
YOY2.8022.588+0.214
5Y2.4482.627-0.179
10Y3.2292.623+0.606
1.3.2. Quick Ratio

Measures if Resmed is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Resmed to the Medical Instruments & Supplies industry mean.
  • A Quick Ratio of 1.25 means the company can pay off $1.25 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Resmed Inc DRC:

  • The MRQ is 1.246. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.246. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.246TTM1.2460.000
TTM1.246YOY1.246+0.000
TTM1.2465Y1.252-0.006
5Y1.25210Y2.159-0.907
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2461.117+0.129
TTM1.2461.127+0.119
YOY1.2461.306-0.060
5Y1.2521.430-0.178
10Y2.1591.533+0.626

1.4. Solvency of Resmed Inc DRC.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Resmed assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Resmed to Medical Instruments & Supplies industry mean.
  • A Debt to Asset Ratio of 0.39 means that Resmed assets are financed with 38.8% credit (debt) and the remaining percentage (100% - 38.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Resmed Inc DRC:

  • The MRQ is 0.388. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.388. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.388TTM0.3880.000
TTM0.388YOY0.340+0.048
TTM0.3885Y0.414-0.026
5Y0.41410Y0.384+0.030
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3880.357+0.031
TTM0.3880.360+0.028
YOY0.3400.353-0.013
5Y0.4140.365+0.049
10Y0.3840.371+0.013
1.4.2. Debt to Equity Ratio

Measures if Resmed is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Resmed to the Medical Instruments & Supplies industry mean.
  • A Debt to Equity ratio of 63.5% means that company has $0.63 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Resmed Inc DRC:

  • The MRQ is 0.635. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.635. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.635TTM0.6350.000
TTM0.635YOY0.516+0.119
TTM0.6355Y0.722-0.087
5Y0.72210Y0.651+0.071
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6350.541+0.094
TTM0.6350.561+0.074
YOY0.5160.551-0.035
5Y0.7220.651+0.071
10Y0.6510.670-0.019

2. Market Valuation of Resmed Inc DRC

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Resmed generates.

  • Above 15 is considered overpriced but always compare Resmed to the Medical Instruments & Supplies industry mean.
  • A PE ratio of 35.84 means the investor is paying $35.84 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Resmed Inc DRC:

  • The EOD is 29.078. Based on the earnings, the company is overpriced. -1
  • The MRQ is 35.839. Based on the earnings, the company is overpriced. -1
  • The TTM is 35.839. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD29.078MRQ35.839-6.760
MRQ35.839TTM35.8390.000
TTM35.839YOY41.517-5.678
TTM35.8395Y23.799+12.039
5Y23.79910Y11.900+11.900
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD29.07814.475+14.603
MRQ35.83915.934+19.905
TTM35.83916.429+19.410
YOY41.51721.990+19.527
5Y23.79920.830+2.969
10Y11.90024.796-12.896
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Resmed Inc DRC:

  • The EOD is 46.665. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 57.514. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The TTM is 57.514. Based on how much money comes from the company's main activities, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD46.665MRQ57.514-10.849
MRQ57.514TTM57.5140.000
TTM57.514YOY165.852-108.339
TTM57.5145Y52.109+5.405
5Y52.10910Y26.054+26.054
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD46.6659.339+37.326
MRQ57.5148.949+48.565
TTM57.5141.445+56.069
YOY165.8523.453+162.399
5Y52.1095.897+46.212
10Y26.054-0.032+26.086
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Resmed is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A PB ratio of 7.79 means the investor is paying $7.79 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Resmed Inc DRC:

  • The EOD is 6.320. Based on the equity, the company is overpriced. -1
  • The MRQ is 7.789. Based on the equity, the company is overpriced. -1
  • The TTM is 7.789. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD6.320MRQ7.789-1.469
MRQ7.789TTM7.7890.000
TTM7.789YOY9.629-1.840
TTM7.7895Y5.557+2.232
5Y5.55710Y2.778+2.778
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD6.3202.416+3.904
MRQ7.7892.753+5.036
TTM7.7892.692+5.097
YOY9.6293.294+6.335
5Y5.5573.659+1.898
10Y2.7784.236-1.458
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Resmed Inc DRC compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.5160.5160%0.323+60%0.280+84%0.171+202%
Book Value Per Share--2.8012.8010%2.285+23%2.031+38%1.631+72%
Current Ratio--3.1223.1220%2.802+11%2.448+28%3.229-3%
Debt To Asset Ratio--0.3880.3880%0.340+14%0.414-6%0.384+1%
Debt To Equity Ratio--0.6350.6350%0.516+23%0.722-12%0.651-2%
Dividend Per Share--0.1750.1750%0.167+5%0.159+10%0.137+28%
Eps--0.6090.6090%0.530+15%0.432+41%0.332+83%
Free Cash Flow Per Share--0.3790.3790%0.133+186%0.333+14%0.294+29%
Free Cash Flow To Equity Per Share--0.6660.6660%0.045+1368%0.305+118%0.197+239%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--3.601--------
Intrinsic Value_10Y_min--1.007--------
Intrinsic Value_1Y_max--0.340--------
Intrinsic Value_1Y_min--0.248--------
Intrinsic Value_3Y_max--1.037--------
Intrinsic Value_3Y_min--0.622--------
Intrinsic Value_5Y_max--1.754--------
Intrinsic Value_5Y_min--0.859--------
Market Cap26034752716.800-24%32167308250.00032167308250.0000%32359579648.000-1%18082910323.280+78%9041455161.640+256%
Net Profit Margin--0.2130.2130%0.218-2%0.189+13%0.187+14%
Operating Margin--0.2700.2700%0.280-3%0.266+2%0.258+5%
Operating Ratio--0.7270.7270%0.720+1%0.7290%0.743-2%
Pb Ratio6.320-23%7.7897.7890%9.629-19%5.557+40%2.778+180%
Pe Ratio29.078-23%35.83935.8390%41.517-14%23.799+51%11.900+201%
Price Per Share17.700-23%21.81521.8150%22.000-1%12.283+78%6.142+255%
Price To Free Cash Flow Ratio46.665-23%57.51457.5140%165.852-65%52.109+10%26.054+121%
Price To Total Gains Ratio25.611-23%31.56531.5650%44.918-30%38.772-19%38.772-19%
Quick Ratio--1.2461.2460%1.246+0%1.2520%2.159-42%
Return On Assets--0.1330.1330%0.153-13%0.124+7%0.124+7%
Return On Equity--0.2170.2170%0.232-6%0.212+3%0.201+8%
Total Gains Per Share--0.6910.6910%0.490+41%0.439+57%0.308+124%
Usd Book Value--4129903000.0004129903000.0000%3360751000.000+23%2989110600.000+38%2400518500.000+72%
Usd Book Value Change Per Share--0.5160.5160%0.323+60%0.280+84%0.171+202%
Usd Book Value Per Share--2.8012.8010%2.285+23%2.031+38%1.631+72%
Usd Dividend Per Share--0.1750.1750%0.167+5%0.159+10%0.137+28%
Usd Eps--0.6090.6090%0.530+15%0.432+41%0.332+83%
Usd Free Cash Flow--559299000.000559299000.0000%195111000.000+187%490465600.000+14%432992500.000+29%
Usd Free Cash Flow Per Share--0.3790.3790%0.133+186%0.333+14%0.294+29%
Usd Free Cash Flow To Equity Per Share--0.6660.6660%0.045+1368%0.305+118%0.197+239%
Usd Market Cap26034752716.800-24%32167308250.00032167308250.0000%32359579648.000-1%18082910323.280+78%9041455161.640+256%
Usd Price Per Share17.700-23%21.81521.8150%22.000-1%12.283+78%6.142+255%
Usd Profit--897556000.000897556000.0000%779437000.000+15%635552800.000+41%488620300.000+84%
Usd Revenue--4222993000.0004222993000.0000%3578127000.000+18%3312306000.000+27%2604106100.000+62%
Usd Total Gains Per Share--0.6910.6910%0.490+41%0.439+57%0.308+124%
 EOD+4 -4MRQTTM+0 -0YOY+24 -115Y+29 -610Y+27 -8

3.2. Fundamental Score

Let's check the fundamental score of Resmed Inc DRC based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1529.078
Price to Book Ratio (EOD)Between0-16.320
Net Profit Margin (MRQ)Greater than00.213
Operating Margin (MRQ)Greater than00.270
Quick Ratio (MRQ)Greater than11.246
Current Ratio (MRQ)Greater than13.122
Debt to Asset Ratio (MRQ)Less than10.388
Debt to Equity Ratio (MRQ)Less than10.635
Return on Equity (MRQ)Greater than0.150.217
Return on Assets (MRQ)Greater than0.050.133
Total8/10 (80.0%)

3.3. Technical Score

Let's check the technical score of Resmed Inc DRC based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than503.275
Ma 20Greater thanMa 5018.448
Ma 50Greater thanMa 10018.815
Ma 100Greater thanMa 20017.963
OpenGreater thanClose17.700
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets6,751,708
Total Liabilities2,621,805
Total Stockholder Equity4,129,903
 As reported
Total Liabilities 2,621,805
Total Stockholder Equity+ 4,129,903
Total Assets = 6,751,708

Assets

Total Assets6,751,708
Total Current Assets2,367,830
Long-term Assets4,383,878
Total Current Assets
Cash And Cash Equivalents 227,891
Short-term Investments 12,423
Net Receivables 704,909
Inventory 998,012
Other Current Assets 437,018
Total Current Assets  (as reported)2,367,830
Total Current Assets  (calculated)2,380,253
+/- 12,423
Long-term Assets
Property Plant Equipment 665,811
Goodwill 2,770,299
Intangible Assets 552,341
Long-term Assets Other 395,427
Long-term Assets  (as reported)4,383,878
Long-term Assets  (calculated)4,383,878
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities758,533
Long-term Liabilities1,863,272
Total Stockholder Equity4,129,903
Total Current Liabilities
Short-term Debt 31,821
Short Long Term Debt 9,902
Accounts payable 150,756
Other Current Liabilities 437,884
Total Current Liabilities  (as reported)758,533
Total Current Liabilities  (calculated)630,363
+/- 128,170
Long-term Liabilities
Long term Debt 1,431,234
Capital Lease Obligations Min Short Term Debt106,951
Other Liabilities 315,185
Long-term Liabilities Other 68,166
Long-term Liabilities  (as reported)1,863,272
Long-term Liabilities  (calculated)1,921,536
+/- 58,264
Total Stockholder Equity
Common Stock588
Retained Earnings 4,253,016
Accumulated Other Comprehensive Income -272,528
Other Stockholders Equity 148,827
Total Stockholder Equity (as reported)4,129,903
Total Stockholder Equity (calculated)4,129,903
+/-0
Other
Capital Stock588
Cash and Short Term Investments 227,891
Common Stock Shares Outstanding 1,474,550
Current Deferred Revenue138,072
Liabilities and Stockholders Equity 6,751,708
Net Debt 1,352,017
Net Invested Capital 5,571,039
Net Tangible Assets 807,263
Net Working Capital 1,609,297
Property Plant and Equipment Gross 665,811
Short Long Term Debt Total 1,579,908



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-302001-06-302000-06-301999-06-301998-06-301997-06-301996-06-301995-06-301994-06-301993-06-30
> Total Assets 
5,200
9,600
35,300
46,900
54,900
64,600
89,900
115,594
288,090
376,191
459,595
544,159
774,146
1,007,221
1,252,042
1,406,000
1,507,968
1,626,397
2,068,922
2,137,869
2,210,721
2,360,962
2,184,260
3,258,935
3,468,487
3,063,923
4,107,682
4,587,376
4,728,125
5,095,853
6,751,708
6,751,7085,095,8534,728,1254,587,3764,107,6823,063,9233,468,4873,258,9352,184,2602,360,9622,210,7212,137,8692,068,9221,626,3971,507,9681,406,0001,252,0421,007,221774,146544,159459,595376,191288,090115,59489,90064,60054,90046,90035,3009,6005,200
   > Total Current Assets 
4,500
8,500
33,000
37,800
44,400
46,600
50,800
69,172
177,882
193,713
241,905
277,829
360,210
510,284
668,799
739,240
853,284
985,341
1,292,452
1,361,151
1,448,849
1,556,209
1,444,182
1,419,719
1,644,003
1,065,717
1,145,366
1,523,459
1,574,757
1,931,478
2,367,830
2,367,8301,931,4781,574,7571,523,4591,145,3661,065,7171,644,0031,419,7191,444,1821,556,2091,448,8491,361,1511,292,452985,341853,284739,240668,799510,284360,210277,829241,905193,713177,88269,17250,80046,60044,40037,80033,0008,5004,500
       Cash And Cash Equivalents 
1,700
3,700
3,300
5,500
9,100
15,500
11,100
18,250
40,136
72,860
114,491
128,907
142,185
219,544
257,792
321,078
415,650
488,776
735,267
809,541
876,048
905,730
717,249
731,434
821,935
188,701
147,128
463,156
295,278
273,710
227,891
227,891273,710295,278463,156147,128188,701821,935731,434717,249905,730876,048809,541735,267488,776415,650321,078257,792219,544142,185128,907114,49172,86040,13618,25011,10015,5009,1005,5003,3003,7001,700
       Short-term Investments 
0
0
0
0
0
0
5,600
3,713
62,616
19,979
6,533
12,021
0
0
19,950
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,167
12,423
12,4239,1670000000000000019,9500012,0216,53319,97962,6163,7135,600000000
       Net Receivables 
1,500
2,400
3,800
6,300
7,800
13,200
17,900
24,688
32,248
46,199
56,694
67,242
103,951
138,147
175,773
209,315
214,163
232,228
283,646
285,442
318,349
359,593
362,568
382,086
450,530
483,681
528,484
474,643
614,292
575,950
704,909
704,909575,950614,292474,643528,484483,681450,530382,086362,568359,593318,349285,442283,646232,228214,163209,315175,773138,147103,95167,24256,69446,19932,24824,68817,90013,2007,8006,3003,8002,4001,500
       Inventory 
1,000
1,000
4,400
6,100
5,800
7,600
10,700
15,802
29,994
41,173
49,386
55,797
89,107
116,194
157,204
158,251
157,431
185,642
200,777
174,351
145,847
165,418
246,859
224,456
268,319
268,701
349,641
416,915
457,033
743,910
998,012
998,012743,910457,033416,915349,641268,701268,319224,456246,859165,418145,847174,351200,777185,642157,431158,251157,204116,19489,10755,79749,38641,17329,99415,80210,7007,6005,8006,1004,4001,0001,000
       Other Current Assets 
300
1,400
21,500
19,900
21,700
10,300
5,500
6,719
12,888
13,502
14,801
13,862
24,967
36,399
58,080
50,596
66,040
78,695
72,762
72,227
108,605
125,468
117,506
81,743
103,219
124,634
120,113
168,745
208,154
337,908
437,018
437,018337,908208,154168,745120,113124,634103,21981,743117,506125,468108,60572,22772,76278,69566,04050,59658,08036,39924,96713,86214,80113,50212,8886,7195,50010,30021,70019,90021,5001,400300
   > Long-term Assets 
700
1,100
2,300
9,100
10,500
18,000
39,100
46,422
110,208
182,478
217,690
266,330
413,936
496,937
583,243
666,760
654,684
641,056
776,470
776,718
761,872
804,753
740,078
1,839,216
1,824,484
1,998,206
2,962,316
3,063,917
3,153,368
3,164,375
4,383,878
4,383,8783,164,3753,153,3683,063,9172,962,3161,998,2061,824,4841,839,216740,078804,753761,872776,718776,470641,056654,684666,760583,243496,937413,936266,330217,690182,478110,20846,42239,10018,00010,5009,1002,3001,100700
       Property Plant Equipment 
500
800
2,000
3,300
4,900
11,100
29,300
36,576
55,092
79,279
104,687
147,268
174,168
245,376
310,580
357,057
377,613
387,148
462,107
434,363
411,433
434,277
387,758
384,276
394,241
386,550
387,460
535,683
592,065
630,495
665,811
665,811630,495592,065535,683387,460386,550394,241384,276387,758434,277411,433434,363462,107387,148377,613357,057310,580245,376174,168147,268104,68779,27955,09236,57629,30011,1004,9003,3002,000800500
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
106,075
181,106
195,612
206,778
234,647
213,169
198,625
235,487
256,209
274,829
289,312
264,261
1,059,245
1,064,874
1,068,944
1,856,449
1,890,324
1,927,901
1,936,442
2,770,299
2,770,2991,936,4421,927,9011,890,3241,856,4491,068,9441,064,8741,059,245264,261289,312274,829256,209235,487198,625213,169234,647206,778195,612181,106106,07500000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14,900
25,600
33,815
38,324
41,226
52,100
0
0
0
0
000052,10041,22638,32433,81525,60014,900000000000000000000000
       Intangible Assets 
100
100
200
4,500
4,800
5,900
7,300
6,968
49,260
95,189
105,905
110,889
230,477
48,897
46,575
46,771
35,023
30,925
47,911
54,827
49,639
45,198
47,142
299,808
261,800
215,184
521,950
448,168
392,582
345,944
552,341
552,341345,944392,582448,168521,950215,184261,800299,80847,14245,19849,63954,82747,91130,92535,02346,77146,57548,897230,477110,889105,90595,18949,2606,9687,3005,9004,8004,500200100100
       Long-term Assets Other 
100
200
100
1,300
800
1,000
2,500
2,878
5,856
8,010
7,098
8,173
9,291
7,052
10,104
7,508
5,261
5,316
12,043
31,319
25,971
35,966
40,917
95,887
103,569
327,528
196,457
189,742
240,820
251,494
395,427
395,427251,494240,820189,742196,457327,528103,56995,88740,91735,96625,97131,31912,0435,3165,2617,50810,1047,0529,2918,1737,0988,0105,8562,8782,5001,0008001,300100200100
> Total Liabilities 
2,300
4,000
6,400
7,900
10,300
13,800
18,300
21,622
187,724
183,261
173,162
182,660
300,081
269,073
320,820
324,225
392,776
338,861
338,185
530,242
600,205
602,714
596,953
1,564,104
1,508,221
1,004,943
2,035,489
2,090,349
1,842,446
1,735,102
2,621,805
2,621,8051,735,1021,842,4462,090,3492,035,4891,004,9431,508,2211,564,104596,953602,714600,205530,242338,185338,861392,776324,225320,820269,073300,081182,660173,162183,261187,72421,62218,30013,80010,3007,9006,4004,0002,300
   > Total Current Liabilities 
1,900
3,500
5,700
7,400
10,000
13,800
18,200
21,622
33,610
49,047
50,583
60,591
218,551
129,000
202,403
192,593
269,100
285,144
208,840
252,852
574,049
269,558
267,259
638,551
360,126
511,249
555,991
602,761
911,766
689,299
758,533
758,533689,299911,766602,761555,991511,249360,126638,551267,259269,558574,049252,852208,840285,144269,100192,593202,403129,000218,55160,59150,58349,04733,61021,62218,20013,80010,0007,4005,7003,5001,900
       Short-term Debt 
100
0
0
300
300
200
0
0
0
0
19,140
22,591
115,435
4,869
28,350
43,865
67,545
94,161
163
52
300,017
18
148,096
300,000
214,985
11,466
11,992
33,250
35,585
31,772
31,821
31,82131,77235,58533,25011,99211,466214,985300,000148,09618300,0175216394,16167,54543,86528,3504,869115,43522,59119,140000020030030000100
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
300,788
0
300,000
0
11,466
11,992
11,987
12,000
9,916
9,902
9,9029,91612,00011,98711,99211,4660300,0000300,788000000000000000000000
       Accounts payable 
800
1,500
2,600
2,400
2,600
3,800
4,800
5,929
7,971
11,605
19,368
18,574
34,416
45,045
53,039
56,308
48,293
57,535
55,194
55,006
60,688
85,405
81,112
92,571
92,763
92,723
115,725
135,786
138,008
159,245
150,756
150,756159,245138,008135,786115,72592,72392,76392,57181,11285,40560,68855,00655,19457,53548,29356,30853,03945,04534,41618,57419,36811,6057,9715,9294,8003,8002,6002,4002,6001,500800
       Other Current Liabilities 
1,000
2,000
3,100
4,700
7,100
9,800
13,400
15,693
25,639
37,442
5,720
10,667
56,373
63,742
102,149
66,287
124,381
103,941
108,358
156,231
168,391
141,765
1,954
195,971
460
346,232
339,607
335,108
628,562
389,615
437,884
437,884389,615628,562335,108339,607346,232460195,9711,954141,765168,391156,231108,358103,941124,38166,287102,14963,74256,37310,6675,72037,44225,63915,69313,4009,8007,1004,7003,1002,0001,000
   > Long-term Liabilities 
400
500
700
500
300
0
100
0
154,114
134,214
122,579
122,069
81,530
140,073
118,417
131,632
123,676
53,717
129,345
277,390
26,156
333,156
329,694
925,553
1,148,095
493,694
1,479,498
1,487,588
930,680
1,045,803
1,863,272
1,863,2721,045,803930,6801,487,5881,479,498493,6941,148,095925,553329,694333,15626,156277,390129,34553,717123,676131,632118,417140,07381,530122,069122,579134,214154,11401000300500700500400
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
32,386
27,410
50,553
69,484
223,706
220,637
221,575
172,550
160,025
315,185
315,185160,025172,550221,575220,637223,70669,48450,55327,41032,386000000000000000000000
> Total Stockholder Equity
2,900
5,600
28,900
39,000
44,600
50,800
71,600
93,972
100,366
192,930
286,433
361,499
474,065
738,148
931,222
1,081,775
1,115,192
1,287,536
1,730,737
1,607,627
1,610,516
1,758,248
1,587,307
1,694,831
1,960,266
2,058,980
2,072,193
2,497,027
2,885,679
3,360,751
4,129,903
4,129,9033,360,7512,885,6792,497,0272,072,1932,058,9801,960,2661,694,8311,587,3071,758,2481,610,5161,607,6271,730,7371,287,5361,115,1921,081,775931,222738,148474,065361,499286,433192,930100,36693,97271,60050,80044,60039,00028,9005,6002,900
   Common Stock
0
0
0
0
0
0
100
122
126
132
134
135
140
303
311
304
303
303
607
568
568
566
562
563
569
571
575
580
583
586
588
588586583580575571569563562566568568607303303304311303140135134132126122100000000
   Retained Earnings 
700
1,800
4,600
9,100
16,600
27,200
43,300
65,507
77,137
114,643
160,372
217,656
282,441
370,652
436,954
548,343
694,791
884,876
1,111,862
1,366,712
1,576,641
1,780,396
1,976,020
2,160,299
2,316,237
2,432,328
2,436,410
2,832,991
3,079,640
3,613,736
4,253,016
4,253,0163,613,7363,079,6402,832,9912,436,4102,432,3282,316,2372,160,2991,976,0201,780,3961,576,6411,366,7121,111,862884,876694,791548,343436,954370,652282,441217,656160,372114,64377,13765,50743,30027,20016,6009,1004,6001,800700
   Capital Surplus 0000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000
   Other Stockholders Equity 
2,200
3,800
24,300
29,900
28,000
23,600
33,600
41,495
52,675
86,280
96,017
102,435
138,600
312,059
378,204
325,359
314,321
315,982
293,836
3,891
-58,781
-174,266
-215,759
-243,373
-167,481
-149,591
-111,783
-52,562
-1,057
59,176
148,827
148,82759,176-1,057-52,562-111,783-149,591-167,481-243,373-215,759-174,266-58,7813,891293,836315,982314,321325,359378,204312,059138,600102,43596,01786,28052,67541,49533,60023,60028,00029,90024,3003,8002,200



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-06-30)

Gross Profit (+$)
totalRevenue4,222,993
Cost of Revenue-1,867,331
Gross Profit2,355,6622,355,662
 
Operating Income (+$)
Gross Profit2,355,662
Operating Expense-1,203,665
Operating Income1,131,8711,151,997
 
Operating Expense (+$)
Research Development287,642
Selling General Administrative874,003
Selling And Marketing Expenses0
Operating Expense1,203,6651,161,645
 
Net Interest Income (+$)
Interest Income0
Interest Expense-47,379
Other Finance Cost-0
Net Interest Income-47,379
 
Pretax Income (+$)
Operating Income1,131,871
Net Interest Income-47,379
Other Non-Operating Income Expenses0
Income Before Tax (EBT)1,101,6641,134,825
EBIT - interestExpense = 1,094,595
1,101,664
944,935
Interest Expense47,379
Earnings Before Interest and Taxes (EBIT)1,141,9741,149,043
Earnings Before Interest and Taxes (EBITDA)1,339,536
 
After tax Income (+$)
Income Before Tax1,101,664
Tax Provision-204,108
Net Income From Continuing Ops897,556897,556
Net Income897,556
Net Income Applicable To Common Shares897,556
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses3,070,996
Total Other Income/Expenses Net-2,95447,379
 

Technical Analysis of Resmed
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Resmed. The general trend of Resmed is NEUTRAL with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Resmed's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (0.0%) Bearish trend (0.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Resmed Inc DRC.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: < < .

The bearish price targets are: 17.70 > 17.70 > 17.70.

Tweet this
Resmed Inc DRC Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Resmed Inc DRC. The current mas is .

The long score for the Moving Averages is 7/14.
The longshort score for the Moving Averages is 0/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Resmed Inc DRC Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Resmed Inc DRC. The current macd is -0.35987629.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Resmed price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Resmed. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Resmed price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Resmed Inc DRC Daily Moving Average Convergence/Divergence (MACD) ChartResmed Inc DRC Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Resmed Inc DRC. The current adx is 89.32.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Resmed shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Resmed Inc DRC Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Resmed Inc DRC. The current sar is 18.74.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Resmed Inc DRC Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Resmed Inc DRC. The current rsi is 3.27457518. The current phase is Oversold in neutral market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Oversold in neutral market:
Resmed Inc DRC Daily Relative Strength Index (RSI) ChartResmed Inc DRC Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Resmed Inc DRC. The current phase is Oversold in neutral market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Resmed price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Resmed Inc DRC Daily Stochastic Oscillator ChartResmed Inc DRC Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Resmed Inc DRC. The current cci is -74.07407407.

Resmed Inc DRC Daily Commodity Channel Index (CCI) ChartResmed Inc DRC Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Resmed Inc DRC. The current cmo is -99.45787191.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Resmed Inc DRC Daily Chande Momentum Oscillator (CMO) ChartResmed Inc DRC Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Resmed Inc DRC. The current willr is -100.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Resmed Inc DRC Daily Williams %R ChartResmed Inc DRC Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Resmed Inc DRC.

Resmed Inc DRC Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Resmed Inc DRC. The current atr is 0.05587848.

Resmed Inc DRC Daily Average True Range (ATR) ChartResmed Inc DRC Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Resmed Inc DRC. The current obv is 160,117.

Resmed Inc DRC Daily On-Balance Volume (OBV) ChartResmed Inc DRC Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Resmed Inc DRC. The current mfi is 0.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Resmed Inc DRC Daily Money Flow Index (MFI) ChartResmed Inc DRC Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Resmed Inc DRC.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-08ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-29MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-26ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-16MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-21WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Resmed Inc DRC Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Resmed Inc DRC based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than503.275
Ma 20Greater thanMa 5018.448
Ma 50Greater thanMa 10018.815
Ma 100Greater thanMa 20017.963
OpenGreater thanClose17.700
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Resmed with someone you think should read this too:
  • Are you bullish or bearish on Resmed? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Resmed? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Resmed Inc DRC

I send you an email if I find something interesting about Resmed Inc DRC.


Comments

How you think about this?

Leave a comment

Stay informed about Resmed Inc DRC.

Receive notifications about Resmed Inc DRC in your mailbox!